Impact of vulnerable plaques detection on coronary prevention
Detecting coronary vulnerable plaques in vivo and assessing their vulnerability have been great challenges for clinicians and the research community. This session will demonstrate how to detect vulnerable plaque and it’s impact on clinical outcomes.
This program is made possible by an unrestricted educational grant from Abbott. The technologies been discussed may not be approved for use in your country.
Gregg W. Stone, MD, FACC, MSCAI is an interventional cardiologist and Director of Academic...Read More
Gregg W. Stone, MD, FACC, MSCAI is an interventional cardiologist and Director of Academic Affairs for the Mount Sinai Heart Health System and Professor of Medicine (Cardiology) and Professor of Population Health Sciences and Policy at the Icahn School of Medicine at Mount Sinai in New York, NY. Dr. Stone has served as the national or international principal investigator for more than 120 national and international multicenter randomized trials (many of which have led to new device approval or indications in the US), has authored more than 2000 manuscripts and abstracts published in the peer-reviewed literature, and has delivered thousands of invited lectures around the world. With a 2018 H-factor of 152, Dr. Stone was recently listed in Nature Medicine as one of the most prolific authors in science. Dr. Stone's areas of expertise include interventional therapies of acute coronary syndromes, myocardial infarction and cardiogenic shock; drug-eluting stents and bioresorbable scaffolds; left main and complex coronary artery disease intervention; antiplatelet and antithrombotic pharmacotherapies; transcatheter valve repair and replacement; interventional hypertension and heart failure therapies; left atrial appendage closure; intravascular imaging (IVUS, OCT and NIRS); vulnerable plaque diagnosis and treatment; adjunctive interventional devices including atherectomy, distal embolic protection, thrombectomy, covered stents, chronic total occlusion devices, and brachytherapy; saphenous vein graft therapies; contrast nephropathy; clinical trial design; and regulatory issues. Dr. Stone is the director of TCT, the world's largest symposium devoted to interventional cardiology and vascular medicine. Dr. Stone founded the annual National Interventional Cardiology Fellow's Course and Transcatheter Valve Therapies TVT), the Chronic Total Occlusion (CTO) Summit, and co-directs multiple other meetings in the US, China, Russia, Europe, S. Korea and elsewhere.Show Less
Dr. Ozan Demir is an Interventional Cardiology Fellow and Clinical Research Fellow at St Thomas’...Read More
Dr. Ozan Demir is an Interventional Cardiology Fellow and Clinical Research Fellow at St Thomas’ Hospital and King’s College London, where he is currently undertaking a PhD in coronary physiology under the supervision of Professor Divaka Perera. He studied Medicine at King’s College London and trained in London prior to undertaking Interventional Cardiology Fellowships at Hammersmith Hospital, London and San Raffaele, Milano. During his Fellowship in Milano, under the supervision of Professor Antonio Colombo and Professor Azeem Latib, he undertook an MSc in Interventional Cardiology at the Università Vita-Salute San Raffaele. He is currently involved in various clinical research studies on coronary physiology.Show Less
Asst. Prof. Pawel Gasior is an interventional cardiology fellow in Division of Cardiology and...Read More
Asst. Prof. Pawel Gasior is an interventional cardiology fellow in Division of Cardiology and Structural Heart Diseases, Medical University of Silesia in Poland. He is a Fellow of the European Society of Cardiology and the currently act as co-chair of the EAPCI New Initiatives for Young Interventionalists Committee. Following graduation from Medical University of Silesia he undertook research fellowship at Cardiovascular Research Foundation in New York under supervision of Dr. Juan Granada. Besides clinical medicine, he is also engaged in both clinical and preclinical research on intravascular imaging, new intravascular technologies, coronary physiology and coronary artery disease.Show Less